DePuy Orthopaedics Newswire (Page 7)

DePuy Orthopaedics Newswire (Page 7)

Comprehensive Real-Time News Feed for DePuy Orthopaedics. (Page 7)

Results 121 - 140 of 1,536 in DePuy Orthopaedics

  1. While you were sleeping: Wall St moves higher on dataRead the original story w/Photo

    Feb 14, 2018 | NBR Newsroom

    Invesco chief global market strategist Kristina Hooper says they're trying to weigh how much each data point is going to matter. Wall Street climbed as investors assessed the impact of US reports showing stronger-than-expected inflation and an unexpected drop in retail sales on expectations for the pace of Federal Reserve interest rate increases this year.

    Comment?

  2. VERIFY | Are there toxins in Johnson's baby shampoo?Read the original story w/Photo

    Feb 13, 2018 | KCEN

    We set out to verify if the below Facebook post, claiming that the baby shampoo made by Johnson and Johnson is poisoning your child, is toxic, and causes cancer. The post has been shared over 800 times.

    Comment?

  3. Surgical Sealants and Adhesives Market to reach USD 3 Billion by 2021 ...Read the original story

    Feb 14, 2018 | Emailwire.com

    Surgical Sealants And Adhesives Market By Product , Indication , Application The Surgical Sealants and Adhesives market is expected to reach USD 2.97 Billion by 2021 from an estimated USD 1.88 Billion in 2016, at a CAGR of 9.6%.Materials that are utilized for fixing injured tissues, stitching the tissues together after injury, and bolstering surgical wounds are known as surgical sealants and adhesives. They are favoured over the conventional methods due to numerous advantages like effectiveness, usability and safety.

    Comment?

  4. Johnson & Johnson (JNJ) Shares Bought by Kwmg LLCRead the original story w/Photo

    Feb 13, 2018 | IntersportsWire

    Kwmg LLC grew its stake in Johnson & Johnson by 23.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,298 shares of the company's stock after buying an additional 3,517 shares during the period.

    Comment?

  5. Johnson & Johnson (JNJ) Given Daily News Sentiment Rating of 0.08Read the original story w/Photo

    Feb 12, 2018 | IntersportsWire

    News headlines about Johnson & Johnson have trended somewhat positive on Monday, Accern Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than 20 million blog and news sources in real-time.

    Comment?

  6. 15 years after 11 uber-wealthy heirs appeared in the controversial...Read the original story w/Photo

    Feb 10, 2018 | Silicon Alley Insider

    Fifteen years ago, Johnson & Johnson heir Jamie Johnson came out with a documentary exploring what it's really like to inherit a fortune. He delved into his own experience growing up wealthy, and also interviewed 10 other young, uber-rich heirs and heiresses.

    Comment?

  7. Eye Care Surgical Devices 2018 Global Market Expected to Grow at CAGR of 7.57% and Forecast to 2022Read the original story

    Feb 8, 2018 | World News Report

    Eye care surgical devices are used to treat eye disorders such as cataract, glaucoma, diabetic retinopathy, diabetic macular edema, and other eye-related surgical disorders. The analysts forecast the global eye care surgical devices market to grow at a CAGR of 7.57% during the period 2018-2022.

    Comment?

  8. Adjuvant Breast Cancer Therapy Market Driven by Rising Incidence of Breast CancerRead the original story

    Feb 7, 2018 | SBWire

    The report presents an in-depth assessment of the market. It does so via quantitative and qualitative insights, past performance, and verifiable market size projections.

    Comment?

  9. Johnson & Johnson (JNJ) Position Lessened by Meag Munich Ergo Kapitalanlagegesellschaft MBHRead the original story w/Photo

    Feb 7, 2018 | Daily Political

    Meag Munich Ergo Kapitalanlagegesellschaft MBH reduced its stake in shares of Johnson & Johnson by 23.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The fund owned 331,334 shares of the company's stock after selling 100,068 shares during the period.

    Comment?

  10. Apple escapes the Dow's 1,500 point drop largely unscathedRead the original story w/Photo

    Feb 5, 2018 | Silicon Alley Insider

    As the Dow cratered more than 1,500 points on Monday afternoon , Apple was the only one of the index's 30 stocks to escape largely unscathed, down a maximum of 1.05%. It's lower by just 0.48% at the time of writing.

    Comment?

  11. Tracking Yacktman Asset Management Portfolio - Q4 2017 UpdateRead the original story w/Photo

    Feb 4, 2018 | Seeking Alpha

    This article is part of a series that provides an ongoing analysis of the changes made to Yacktman's US stock portfolio on a quarterly basis. It is based on Yacktman Asset Management's regulatory 13F Form filed on 02/02/2018.

    Comment?

  12. Breton Hill Capital Ltd. Sells 2,805 Shares of Johnson & JohnsonRead the original story w/Photo

    Feb 3, 2018 | The Breeze

    Breton Hill Capital Ltd. decreased its holdings in shares of Johnson & Johnson by 8.4% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 30,761 shares of the company's stock after selling 2,805 shares during the quarter.

    Comment?

  13. You can't make an omelette without breaking a few eggs. Surgeon is...Read the original story w/Photo

    Feb 2, 2018 | Wisbech Standard

    You can't make an omelette without breaking a few eggs. Surgeon is criticised for dismissing the scale of women's suffering in the mesh implant scandal Linda Cardozo, OBE, is a spokesman for the Royal College of Obstetrics and Gynaecology.

    Comment?

  14. Principal Financial Group Inc. Has $780.36 Million Stake in Johnson & JohnsonRead the original story w/Photo

    Feb 1, 2018 | Daily Political

    Principal Financial Group Inc. lifted its stake in shares of Johnson & Johnson by 3.3% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,002,294 shares of the company's stock after buying an additional 193,032 shares during the quarter.

    Comment?

  15. Johnson & Johnson Comments on Remicade Sales Decline, Biosimilar CompetitionRead the original story w/Photo

    Jan 31, 2018 | jdsupra.com

    Last week, Johnson & Johnson held its earnings call for the fourth quarter of 2017. During the call, company representatives discussed an 8% decline in U.S. sales for Remicade as Johnson & Johnson "continued to compete in the phase of biosimilar entries."

    Comment?

  16. Drug companies sell us remedies for problems caused by their own...Read the original story w/Photo

    Jan 31, 2018 | Salon

    Like most folks, you dutifully rub shampoo into your hair daily or a few times each week. After it strips out your hair's natural moisture and liveliness, you apply a conditioner to get that moisture and liveliness back.

    Comment?

  17. Latin America Intraocular Lens Market - Industry, Analysis, Research, ...Read the original story

    Jan 30, 2018 | Emailwire.com

    Latin America Intraocular Lens Market is thriving owing to the wide ranging product portfolio of key market players such as Johnson & Johnson and others The Latin America Intraocular Lens Market is worth USD xx million in 2017 and estimated to grow at a CAGR of xx.xx%, to reach USD xx million by 2022. The Latin America Intraocular Lens market is developing at an exceptionally quick pace.

    Comment?

  18. Capsule Endoscopy Market - An Immortal Market with a Stunning CAGR of ~9.2% by 2023Read the original story w/Photo

    Jan 30, 2018 | SBWire

    MarketResearchFuture.com adds "Capsule Endoscopy Market -2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023" reports to its database. TRY SAMPLE REPORT @ .

    Comment?

  19. Pfizer books $11 billion tax gainRead the original story w/Photo

    Jan 30, 2018 | RTE.ie

    Pfizer has beaten analysts' estimate for adjusted profit, helped by strong demand for its pneumonia vaccine Prevnar and breast cancer drug Ibrance. The drugmaker joins several pharmaceutical companies, including Johnson & Johnson and AbbVie, which are expecting to benefit from the recent tax overhaul.

    Comment?

  20. Johnson & Johnson (JNJ) Shares Sold by Covington Investment Advisors Inc.Read the original story w/Photo

    Jan 30, 2018 | Daily Political

    Covington Investment Advisors Inc. reduced its holdings in Johnson & Johnson by 2.8% in the third quarter, HoldingsChannel reports. The firm owned 27,588 shares of the company's stock after selling 805 shares during the period.

    Comment?